MedPath

Effect of Gabapentin on prevention of Delirium

Phase 3
Conditions
Coronary Heart Disease, Delirium, Open Coronary Heart Surgery.
Delirium due to known physiological condition
Registration Number
IRCT20200306046706N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

All patients undergoing Coronary Artery Bypass Graft Surgery

Exclusion Criteria

History of taking anticonvulsants,
History of Gabapentin drugs consumption in the last two weeks
History of proven psychological problems
Emergency surgery
ICU Admision before surgeon
Delirium before surgery
History of previous cardiac surgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Permitted delirium according to the CAM-IC criteria. Timepoint: Examine delirium twice daily, days 1, 2, 3. Method of measurement: Confusion Assessment Method-ICU.
Secondary Outcome Measures
NameTimeMethod
Postoperative mortality. Timepoint: Death occurring from 36 hours to one month after surgery. Method of measurement: Phone Follow up.
© Copyright 2025. All Rights Reserved by MedPath